An assessment on the uses of Loranthaceae in ethno pharmacology in Cameroon: A case study made in Logbessou, North of Douala

Journal of Medicinal Plants Research

Volumn 3, Issue 8, 2009, Pages 592-595

  Didier, Dibong Siegfried ^a   Laurier, Engone Obiang Nestor ^b   Din, Ndongo ^a   Jules, Priso Richard ^a   Victor, Taffouo ^a   Henri, Fankem ^a   Georges, Salle ^c   Didier, Missoup Alain ^a,d   Joseph, Boussim Issaka ^e   Akoa, Amougou ^f  

^a UNIVERSITY OF DOUALA   (Cameroon)

^b Tropical Ecology Research Institute   (Gabon)

^c SORBONNE UNIVERSITÉ   (France)

^d MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^e UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^f UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Ethno pharmacology; Loranthaceae; Questionnaire; Traditional healers

Indexed keywords

HERBACEOUS AGENT;

ARTICLE; CAMEROON; CASE STUDY; CLINICAL EVALUATION; DISEASE CONTROL; DRUG MECHANISM; ETHNOPHARMACOLOGY; INTERVIEW; LORANTHACEAE; MEDICINAL PLANT; NONHUMAN; PHRAGMANTHERA CAPITATA; STRUCTURED QUESTIONNAIRE; TRADITIONAL MEDICINE;

LORANTHACEAE;

EID: 73449138211     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Balle S (1982). Loranthacées, Flore du Cameroun, vol. 23, Satabié B., Leroy J. F., Yaoundé, Cameroun p. 82
2. Baudino S, Sallé G (1987). Les substances actives du gui. Propriétés pharmacologiques et applications thérapeutiques. Annales des Sciences Naturelles, Botanique 13(8): 45-72.
3. Bauer C, Oppel T, Rueff F (2005). Anaphylaxis to viscotoxins of mistletoe (Viscum album) extracts. Ann. Allergy Asthma. Immunol. 94: 86-89.
4. Cook NC, Samman S (1996). Flavonoids chemistry metabolism, cardioprotective effect, and dietary sources. Nutr. Biochem. 7: 66-76.
5. Dahdouh-Guebas F, Mathenge C, Kairo JG, Koedam N (2000). Utilisation of mangrove wood products around Mida creek (Kenya) among subsistence and commercial users. Econ. Bot. 54(4): 513-527.
6. Deliorman D, Calis I, Ergun F (2000). Studies on the vascular effects of the fractions and phenolic compounds isolated from Viscum album ssp.album. J. Ethnopharmacol. 72: 323-329.
7. Deliu C, Stirban M (1976). Annual dynamics of assimilatory pigments in V. album and its host plant, Populus tremula L. Contrib. Bot., Gradina. Bot. Univ. Babes-Bolyai Cluj. 8: 243-249.
8. Dibong SD, Din N, Priso RJ, Taffouo VD, Fankem H, Sallé G, Amougou A. 2008. Parasitism of host trees by the Loranthaceae in the region of Douala (Cameroon). Afr. J. Environ. Sci. Technol. 2(11): 22-30.
9. Dibong SD, Engoné Obiang NL, Din N, Priso RJ, Taffouo VD, Fankem H, Sallé G, Amougou A (2009a). Artificial infestations of Tapinanthus ogowensis (Engler) Danser (Loranthaceae) on three host species in thr Logbessou Plateau (Douala, Cameroon). Afr. J. Biotechnol. 8(6): 1044-1051.
10. Dibong SD, EngonéObiang NL, Din N, Priso RJ, Taffouo VD, Fankem H, Sallé G, Amougou A (2009b). Niveau d'infestation des arbres fruitiers des groupements végétaux par Phragmanthera capitata (Sprengel) S. Balle (Loranthaceae) dans la région littorale du Cameroun. Int. J. Chem. Sci. 3(2): 347-454.
11. Din N, Priso JR, Dibong SD, Amougou A (2008). Logging activities in mangrove forests: A case study of Douala Cameroon. Afr. J. Environ. Sci. Technol. 2(2): 22-30.
12. Ergun F, Deliorman D, Akar F (1995). Screening of various Viscum album L. Samples of their possible vascular effects. Guede. J. Fac. Pharm. Gazi. 12: 153-158.
13. Ersnt E, Schmidt K, Steuer-Vogt MK (2003). Mistletoe for cancer? Int. J. Cancer 107: 262-267.
14. Frankel EN, Waterhouse AL, Teissedere PL (1995). Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoprotein. I. Afr. Food Chem. 43: 890-894.
15. Gaultier R (1938). Le gui de chěne. Aesculape 28: 89-94.
16. Glatzel G (1983). Mineral nutrition and water relations of hemiparasitic Mistletoes : a question of partitioning. Experiments with Loranthus europaeus on Quercus petraea and Quercus robur. Oecologia 56: 193-201.
17. Gray AM, Flatt PR (1999). Insulin-secreting activity of the traditional antidiabetic plant Viscum album (mistletoe). J. Endocrinol. 160: 409-414.
18. Grossarth-Maticek R, Ziegler R (2007). Prospective controlled cohort studies on long- term therapy of cervical cancer patients with a mistletoe preparation (Iscador). Forsch Komplementarmed 14: 140-147.
19. Grossarth-Maticek R, Ziegler R (2008). Randomized and non randomized prospective controlled cohort studies in matched pair design for the long term therapy of Corpus uteri cancer patients with a mistletoe preparation (Iscador). Eur. J. Med. Res. 13: 107-120.
20. Halliwell BJ (1994). Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 23: 21-48.
21. Harmsma M, Gromme M, Ummelen M (2004). Differential effects of Viscum album extracts Iscador Qu on cell cycle progression and apoptosis in cancer cells. Int. J. Oncol. 25: 1521-1529.
22. Harvey J, Colin-Jones DG (1981). Mistletoe hepatitis. Br. Med. J. (clin. Res. Ed) 282: 186-187.
23. Kampa M, Hatzoglou A, Notas G, Damianaki A, Bakogeorgou E, Gemetzi C, Kouroumalis E, Martin PM, Castanas E (2000). Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cells lines. Nutr. Cancer 37: 223-233.
24. Karakas A, Turker AU, Gunduz B (2008a). Effect of European Mistletoe (Viscum album L. Subsp. album) extracts on activity rhythms of the syrian hamsters (Mesocricetus auratus). Nat. Prod. Res. 22: 996-1006.
25. Karakas A, Serin E, Gunduz B, Turker AU (2008b). The effects of Mistletoe (Viscum album L. subsp. Album) extracts on isolated intestinal contractions. Turk. J. Biol. 32:237-242.
26. Kehrer JP (1993). Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 23: 21-48.
27. Kienle GS, Kiene H (2007). Complementary cancer therapy: a systematic review of propective clinical trials on anthroposophic Mistletoe extracts. Eur. J. Med. Res. 12: 103-119.
28. Krenzelok EP, Jacobsen TD, Aronis J (1997). A mistletoe exposures. Am. J. Emerg. Med. 15: 516-520.
29. Krivokapic C (1977). Plant growth substances in Viscum album L. Proc. Int. Symp. Plant Growth Regulators, Sofia pp. 286-294.
30. Lemesle R, Dupuy P (1971). Le gui (Viscum album). Morphologie, biologie, propriétés. Quart. J. Crude Drug. Res. 11: 1721-1726.
31. Lutomski J (1986). Evaluation of the hypotensional activity of some mistletoe (Viscum album L.) drugs. Int. Meeting on Viscum album, Heidelberg.
32. Mahfouz MM, Ghaleb HA, Zawawy A, Scheffler A (1998). Signifiant tumor reduction, improvement of pain and quality of life and normalization of sleeping patterns of cancer patients treated with a high dose of mistletoe. Ann. Oncol. 9(2): 129-138.
33. Marfak A (2003). Radiolyse gamma des flavonoïdes. Etude de leur activité avec les radicaux issus des alcools : formation des depsides. Thèse de Doctorat de la Faculté de Pharmacie de Limoges p. 220
34. Matthes H, Schad F, Buchward D, Schenk G (2005). Endoscopic ultrasound-guided fine needle injection of Viscum album L. (mistletoe; Helixor M) in the therapy of primary inoperable pancreas cancer: a pilot study. Gastroenterol. 128 (4 suppl. 2): 433, T988.
35. Mengs U, Gothel D, Leng-Peschlow E (2002). Mistletoe extracts standardized to mistletoe lectins in oncology: Review on current status of preclinical research. Anticancer Res. 22: 1399- 1405.
36. Middleton E Jr (1996). Biological properties of plant flavonoids. An overview. Int. J. Pharmacogn. 34: 344-348.
37. Obata Y (1941). The components of Viscum album III. The unsaponifiable matter of the leaves, the so-called &-viscol and &-viscol. J. Agr. Chem. Soc. Japan 17: 784-786.
38. Oboh IE, Nworgu ZAM (2008). Oxytocic properties of the aqueous extract of Globimetula braunii (Loranthaceae). Pak. J. Pharm. Sci. 21:356-360.
39. Okpuzor J, Kareem G, Ejikeme C (2009). Lipid Lowering Activity of Globimetula braunii. Res. J. Med. Plant pp. 1-7.
40. Onal S, Timur S, Okutucu B (2005). Inhibition of alpha-glucosidase by aqueous extracts of some potent antidiabetic medicinal herbs. Prep. Biochem. Biotechnol. 35: 29-36.
41. Orhan DD, Aslan M, Sendogdu N (2005). Evaluation of the hypoglycemic effect and antioxidant activity of three Viscum album subspecies (European mistletoe) in streptozotocin-diabetic rats. J. Ethnopharmacol. 98: 95-102.
42. Radenkovic M, Ivetic V, Popovic M (2006). Neurophysiological effects of mistletoe (Viscum album L.) on isolated rat intestines. Phytother. Res. 20: 374-377.
43. Rosell S, Samuelsson G (1966). Effect of mistletoe viscotoxin and phoratoxin on blood circulation. Toxicon 4: 107-110.
44. Sallé G (1978). Origin and early growth of the sinkers of Viscum album L. Protoplasma 96: 267-273.
45. Spiller HA, Willias DB, Gorman SE, Sanftleban J (1996). Retrospective study of mistletoe ingestion. Clin. Toxicol. 34: 405-408.
46. Sporn MB (1980). Combination chemoprevention of cancer. Nature 287: 107.
47. Swanson-Flatt SK, Day C, Bailey CJ, Flatt PR (1989). Evaluation of traditional plant treatments for diabetes: Studies in streptozotocin diabetic mice. Acta Diabetologica Latina 26: 51-55.
48. Tenario FA, del Valle L, Gonzalez A (2005). Vasodilator activity of the aqueous extract of Viscum album. Fitoterapia 76: 204-209.
49. Urech K, Scher JM, Hostanska K (2005). Apoptosis inducing activity of viscin, a lipophilic extract from Viscum album L. J. Pharm. Pharmacol. 57: 101-109.